logo-loader

Creso Pharma subsidiary Mernova granted sales license from Health Canada

Last updated: 05:38 12 Jun 2020 AEST, First published: 15:38 11 Jun 2020 AEST

Creso Pharma (ASX:CPH) subsidiary Mernova managing director Jack Yu and vice president Isaac Allen joined Steve Darling from Proactive to discuss the granting of their sales license from Health Canada and what it allows them to do.

Isaac Allen tells Proactive they are gearing up sales efforts and see a number of avenues to increase sales growth.

Poseidon Nickel signs binding agreement with Mineral Resources to divest...

Departing Poseidon Nickel Ltd (ASX:POS, OTC:PSDNF) CEO Craig Jones and incoming CEO Brendan Shalders join Proactive’s Jonathan Jackson to discuss the divestment of Lake Johnston to Mineral Resources Ltd (ASX:MIN). Jones, who has played a pivotal role in this strategic move, shared insights on...

8 hours, 27 minutes ago